Competition Clearance of Mergers and Acquisitions in Pakistan

A merger can raise competition concerns even where the corporate transaction is properly authorised under company law. Purchasers and sellers should therefore determine early whether the Competition Commission of Pakistan's merger-control framework applies and whether a transaction may complete before clearance.

Define the transaction and the undertakings

An acquisition of shares, assets or control may qualify for analysis under the Competition Act, 2010 and applicable Merger Control Regulations. The legal form should not obscure the economic effect of combining undertakings. The parties must identify the entities involved, the nature of control acquired, their relevant turnover or assets and whether the statutory thresholds or other notification conditions are met. A group restructure may require a different analysis from a purchase by an unrelated competitor, but neither should be assumed exempt without reviewing the operative rules.

The threshold inquiry has two stages

Section 11 of the Competition Act, 2010 makes pre-merger clearance a separate statutory question from the validity of the acquisition under company law. Regulation 4 of the Competition (Merger Control) Regulations, 2016, as amended uses a combination of financial criteria and transaction-specific criteria. It should not be paraphrased as a single turnover test.

For merger parties other than asset management companies, the financial limb addresses gross assets excluding goodwill—PKR 300 million for the relevant undertaking or PKR 1 billion on a combined basis—or annual turnover in the preceding year of PKR 500 million for the undertaking or PKR 1 billion combined. The additional transaction limb concerns shares or assets of at least PKR 100 million, or a voting-share acquisition which, together with the acquirer's existing voting shares, entitles the acquirer to more than 10 per cent of voting shares. The drafting must be read as a connected set of alternatives: the financial limb is assessed alongside the transaction limb, not treated as an independent automatic filing trigger.

Calculations must identify the correct undertakings, consolidated or relevant financial figures and existing holdings. The separate asset-management-company test under regulation 4(3) requires specific analysis; ordinary-company thresholds should not be mechanically applied to an AMC transaction. A filing memorandum should set out the figures, their source documents and the precise limb relied upon. The Commission may revise notification thresholds by Gazette notification, so parties must confirm the operative text for the contemplated transaction.

Market definition affects the substantive question

A competition assessment may consider whether the transaction materially reduces rivalry in a relevant product or geographic market. The relevant alternatives available to customers, switching costs, barriers to entry and access to distribution channels matter more than the parties' self-description. High combined market share may attract scrutiny, but the analysis should consider the competitive constraints actually present. Transactions involving digital platforms may require attention to networks, data or user access as well as conventional sales. A buyer should not wait until the notification stage to discover that a key competitor is part of the acquired business.

Not every share purchase is treated in the same way

The Regulations expressly address acquisitions of direct or indirect control and certain lasting, independently functioning joint ventures. Regulation 3 looks beyond the label used in the sale agreement, including contractual rights that may give an investor decisive influence over an undertaking. In diligence, the relevant documents can therefore include shareholders' agreements, reserved-matter vetoes, governance arrangements and instruments carrying voting rights—not merely a share-transfer form.

Regulation 5 also contains defined notification exemptions, including particular intra-group combinations, some ordinary-course securities transactions and qualifying acquisitions by inheritance, gifts and rights issues. Those exceptions must be tested against their actual wording and the transaction facts. A group relationship does not excuse an unrelated acquisition, and a holding described as passive may need closer examination if it grants controlling influence. Importantly, the regulation states that a transaction exempt from pre-merger notification may still be subject to substantive competition review where the Commission considers that appropriate.

Foreign incorporation is not, by itself, an exclusion. The merger-control regulations extend to merger parties incorporated outside Pakistan where the relevant undertakings do business in Pakistan. The Commission's published merger guidance likewise addresses foreign parties and joint ventures. For cross-border acquisitions, the Pakistan nexus and relevant transaction structure need to be established on evidence before a decision is taken not to notify.

Regulatory timing belongs in the acquisition timetable

The transaction documents should specify which party prepares the filing, how information is exchanged, what conditions may be offered and who bears the risk of delayed or adverse clearance. The parties should address confidentiality because competitively sensitive information may need protection while they remain independent businesses. Interim covenants must not allow premature coordination or implementation where completion is conditional on approval. The long-stop date should reflect the realistic statutory process and requests for additional information. Signing and closing should be distinguished in both financing documents and public communications.

Capital-market transactions and the filing clock

Regulation 4(1) contemplates notification once merger parties agree in principle or sign a non-binding letter of intent, and before consummation. Regulation 4(1A), inserted in 2019, states a particular rule for capital-market transactions under which the concerned undertakings seek clearance within 15 days after the transaction on the prescribed form. This is a specialised provision; it should neither be omitted from a public explanation nor used to imply that ordinary acquisitions may routinely close before clearance. Parties should verify whether the actual transaction falls within that provision rather than treating the 15-day rule as a general grace period.

The prescribed application and any applicable processing fee must be addressed under regulation 6, including the fee amendments recorded in the Commission's consolidated regulations and the 2024 Gazette notification. Filing preparation requires a description of the parties and group structure, the shares or business being acquired, transaction documents, relevant markets and a reasoned basis for market-share estimates. Regulation 8 requires notice of the application to the other merger parties. Where confidentiality is necessary, the production of documents and commercially sensitive information must be managed in accordance with the Commission's procedures and the parties' independent competition-law obligations.

The nominal first-phase period is 30 working days under regulation 11, and a second-phase review is subject to 90 working days under regulation 12. Crucially, regulation 9 makes completeness relevant to when the first clock begins; the second-phase period depends on notification of the phase and receipt of required information. A timetable calculated from the day a deficient form was emailed to the Commission is not a reliable closing plan. Although statutory no-objection consequences are provided for certain failures to decide within prescribed periods, parties should evaluate the precise circumstances and obtain a defensible clearance position rather than assume silence is automatically sufficient.

Remedies must be commercially feasible

A regulator may be concerned about particular assets, contractual restrictions or concentrated market segments. Any proposed remedy should be assessed for its practical effect on the acquisition's value. Divestiture, access commitments or changes to distribution contracts can alter the economics of the deal. The agreement should state whether the buyer must accept such conditions and the consequences of refusal. A seller should not promise unconditional closing where material remedies could remove the very assets the purchaser intended to acquire.

What the Commission examines and how a deal should be documented

Regulation 10 directs attention to the likelihood of a substantial prevention or lessening of competition. The stated factors include import competition, barriers to market entry, concentration and past collusion, countervailing buyer power, innovation, vertical integration, potential failure of a business and the removal of an effective competitor. These are factual inquiries. A combined market-share number is material, but is not a substitute for evidence about product substitutes, distribution restrictions, customers and the ability of other suppliers to expand.

In a horizontal acquisition, diligence should examine whether the buyer and target compete for the same customers and whether the transaction removes a meaningful competitive constraint. In a vertical acquisition, the inquiry may instead concern inputs, distribution access or the ability and incentive to disadvantage rivals. Where the parties claim efficiencies, section 11(10) of the Competition Act and regulation 15 provide the framework for assessing efficiency arguments in a transaction that otherwise raises substantial concerns. Assertions that integration will improve services should be supported by evidence identifying what changes, why the efficiencies depend on the merger and how they bear on competitive effects.

The share-purchase or business-transfer agreement should therefore contain a workable regulatory condition precedent, a clear responsibility matrix for notification and responses, access to needed information, appropriate safeguards against pre-clearance coordination, a long-stop date and a negotiated allocation of remedy risk. A contractual commitment to pursue every possible remedy is materially different from one permitting the buyer to refuse divestiture of a core business. Lawyers and commercial teams should settle that allocation before the price, financing and completion mechanics become difficult to change.

Clearance must be priced into the transaction

Competition diligence is part of deal valuation and closing strategy, not a late regulatory formality. The parties need a defensible classification, credible market analysis and a contract that allocates the risk of clearance. Company-law validity does not answer the competition-law question.

Primary legal materials and further reading

This analysis should be read with section 11 of the Competition Act, 2010 (Pakistan Code), particularly its provisions on prior clearance, the Commission's review powers and possible conditions; the Competition (Merger Control) Regulations, 2016, consolidated as amended (CCP), especially regulations 3–12 and 15; and the Commission's published merger-control FAQs. The first-phase and second-phase order libraries provide useful examples of how the authority addresses actual transactions. Primary statutory text and the latest published notifications take precedence over explanatory summaries.

Before relying on a threshold, fee or procedural timetable, check the operative Gazette instruments and whether any amendment, special sector-specific approval or applicable condition changes the analysis. The figures and processes above are a general legal framework, not a transaction-specific clearance opinion.